• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    CTS Corporation Announces Appointment of Amy M. Dodrill to its Board of Directors

    2/8/24 5:30:00 PM ET
    $CTS
    $PRCT
    Electrical Products
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $CTS alert in real time by email

    LISLE, Ill., Feb. 08, 2024 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS), a leading global designer and manufacturer of custom engineered solutions that "Sense, Connect and Move," today announced that Amy M. Dodrill has been appointed to its board of directors, effective February 8, 2024, and will serve as a member of the nominating, governance and sustainability and technology and transactions committees.

    Ms. Dodrill comes to CTS with over 25 years of experience in medical and technology companies and a proven track record of successfully leading and profitably growing global businesses serving key end markets. Ms. Dodrill most recently served as President of Baxter's Global Surgical Solutions and Patient Support Systems segment, a $2 billion business with innovative products focused on advancing connected care and patient outcomes. In that role, Ms. Dodrill successfully integrated two former Hillrom business units into Baxter. Ms. Dodrill is a member of the board of directors of Procept BioRobotics (NASDAQ:PRCT), a commercial stage surgical robotics company, serving on the audit and compensation committees.

    "CTS is pleased to welcome Amy Dodrill to the CTS board.   Her extensive experience in the medical end market and background leading global businesses make her a valuable addition to our already highly experienced and diverse group of directors as CTS continues to focus on growth, end-market diversification, and products that sense, connect and move," said Kieran O'Sullivan, Chairman, President and CEO of CTS.

    About CTS

    CTS (NYSE:CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, and transportation markets. For more information, visit www.ctscorp.com.

    Contact

    Ashish Agrawal

    Vice President and Chief Financial Officer

    CTS Corporation

    4925 Indiana Avenue

    Lisle, IL 60532

    USA

    Telephone: +1 (630) 577-8800

    Email: [email protected]



    Primary Logo

    Get the next $CTS alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CTS
    $PRCT

    CompanyDatePrice TargetRatingAnalyst
    PROCEPT BioRobotics Corporation
    $PRCT
    7/9/2025$70.00Overweight
    Stephens
    PROCEPT BioRobotics Corporation
    $PRCT
    7/7/2025Perform
    Oppenheimer
    PROCEPT BioRobotics Corporation
    $PRCT
    12/2/2024$105.00Overweight
    Morgan Stanley
    PROCEPT BioRobotics Corporation
    $PRCT
    11/14/2024$95.00Hold
    Jefferies
    CTS Corporation
    $CTS
    2/7/2024$46.00Buy → Neutral
    Sidoti
    CTS Corporation
    $CTS
    2/7/2024$38.00 → $46.00Market Perform
    TD Cowen
    PROCEPT BioRobotics Corporation
    $PRCT
    8/11/2023$42.00Overweight
    Piper Sandler
    PROCEPT BioRobotics Corporation
    $PRCT
    5/31/2023Outperform
    William Blair
    More analyst ratings

    $CTS
    $PRCT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Aquablation® Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

      SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ:PRCT) (the "Company"), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that Aquablation therapy was assigned a Category I code effective January 1, 2026. The 2026 Medicare Proposed Physician Fee Schedule (PFS) includes payment rates for a new Category I Current Procedural Terminology (CPT) code related to Aquablation therapy. Category I CPT code 52XX1 will replace Category III CPT code 0421T as the primary code for Aquablation therapy. "Securing a Category I CPT Code marks a major milestone for PROCEPT, the urology communit

      7/14/25 9:15:00 PM ET
      $PRCT
      Medical/Dental Instruments
      Health Care
    • CTS Corporation Announces Date for Second Quarter 2025 Earnings Release and Conference Call

      LISLE, Ill., July 14, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS) will release its earnings for the second quarter 2025 at approximately 8:00 a.m. (ET) on Thursday, July 24, 2025. A conference call to discuss second quarter 2025 results with management is scheduled for Thursday, July 24, 2025 at 10:00 a.m. (ET). The dial-in numbers for access from the U.S. are: +1-833-470-1428 (Toll-Free) and +1-404-975-4839 (Local), if calling from outside the U.S., please refer to Global Dial In Numbers to identify the applicable dial-in number for your location. The passcode is 932754. A live audio webcast of the conference call will be available and can be accessed directly from the Investors

      7/14/25 6:01:07 PM ET
      $CTS
      Electrical Products
      Technology
    • CTS Corporation Announces the Appointment of Mark Pacioni as Chief Legal & Administrative Officer and Corporate Secretary

      LISLE, Ill., July 01, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS) today announced that Mark Pacioni has been appointed Chief Legal & Administrative Officer and Corporate Secretary, effective July 1, 2025. Prior to joining CTS, Mr. Pacioni served as Chief Legal Officer and Secretary of CareerBuilder, LLC from 2019 to 2024 and its successor company, CareerBuilder + Monster, from 2024 until June 2025. Prior thereto, he held senior legal roles at The Boeing Co., Molex, Inc., and Knowles Corp. In addition to his in-house experience, Mr. Pacioni was in private practice representing public companies on transactions and governance matters and was Special Counsel at the U.S. Securities and

      7/1/25 9:00:00 AM ET
      $CTS
      Electrical Products
      Technology

    $CTS
    $PRCT
    Leadership Updates

    Live Leadership Updates

    See more
    • CTS Corporation Announces the Appointment of Mark Pacioni as Chief Legal & Administrative Officer and Corporate Secretary

      LISLE, Ill., July 01, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS) today announced that Mark Pacioni has been appointed Chief Legal & Administrative Officer and Corporate Secretary, effective July 1, 2025. Prior to joining CTS, Mr. Pacioni served as Chief Legal Officer and Secretary of CareerBuilder, LLC from 2019 to 2024 and its successor company, CareerBuilder + Monster, from 2024 until June 2025. Prior thereto, he held senior legal roles at The Boeing Co., Molex, Inc., and Knowles Corp. In addition to his in-house experience, Mr. Pacioni was in private practice representing public companies on transactions and governance matters and was Special Counsel at the U.S. Securities and

      7/1/25 9:00:00 AM ET
      $CTS
      Electrical Products
      Technology
    • Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner

      SAN CARLOS, Calif., Oct. 28, 2024 /PRNewswire/ -- Sonder Capital, a leading healthcare venture firm focused on innovative technologies ushering in a new standard of care in medicine, announced the addition of Deborah Kilpatrick, Ph.D., former CEO of Evidation Health and co-founder of MedtechWomen, as a Venture Partner. Kilpatrick earned her Ph.D. from Georgia Tech in mechanical engineering with a focus in bioengineering and a minor in applied mathematics. Most recently, she was the CEO and Executive Chair of the Board at Evidation Health, a technology company that pioneered th

      10/28/24 7:00:00 AM ET
      $ISRG
      $PRCT
      $SNBR
      $SWAV
      Industrial Specialties
      Health Care
      Medical/Dental Instruments
      Home Furnishings
    • Jupiter Endovascular Exits Stealth With $21M in New Financing to Fund Pivotal Trial for Pulmonary Embolism

      Carl J. St. Bernard Appointed as Chief Executive Officer Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal ControlTM to bring the precision and control of direct surgical access to catheter-based interventions, announced today that it has exited stealth mode with a $21 million new round of financing. Sonder Capital was a key participant in the round that included participation from multiple strategic investors. The funding will be used to support the company's upcoming pivotal trial for Pulmonary Embolism and development of additional clinical applications of the Endoportal ControlTM technology. "For decades, the

      8/15/24 10:00:00 AM ET
      $ISRG
      $PRCT
      Industrial Specialties
      Health Care
      Medical/Dental Instruments

    $CTS
    $PRCT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Stephens initiated coverage on PROCEPT BioRobotics with a new price target

      Stephens initiated coverage of PROCEPT BioRobotics with a rating of Overweight and set a new price target of $70.00

      7/9/25 8:44:45 AM ET
      $PRCT
      Medical/Dental Instruments
      Health Care
    • Oppenheimer initiated coverage on PROCEPT BioRobotics

      Oppenheimer initiated coverage of PROCEPT BioRobotics with a rating of Perform

      7/7/25 8:02:36 AM ET
      $PRCT
      Medical/Dental Instruments
      Health Care
    • Morgan Stanley initiated coverage on PROCEPT BioRobotics with a new price target

      Morgan Stanley initiated coverage of PROCEPT BioRobotics with a rating of Overweight and set a new price target of $105.00

      12/2/24 7:01:00 AM ET
      $PRCT
      Medical/Dental Instruments
      Health Care

    $CTS
    $PRCT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Pacioni Mark R.

      3 - CTS CORP (0000026058) (Issuer)

      7/10/25 1:58:26 PM ET
      $CTS
      Electrical Products
      Technology
    • Director Desai Antal Rohit sold $4,719,492 worth of shares (75,000 units at $62.93) and was granted 1,538 shares, increasing direct ownership by 22% to 8,403 units (SEC Form 4)

      4 - PROCEPT BioRobotics Corp (0001588978) (Issuer)

      6/12/25 7:28:32 PM ET
      $PRCT
      Medical/Dental Instruments
      Health Care
    • Director Moll Frederic H was granted 1,538 shares, increasing direct ownership by 0.18% to 843,159 units (SEC Form 4)

      4 - PROCEPT BioRobotics Corp (0001588978) (Issuer)

      6/12/25 4:27:36 PM ET
      $PRCT
      Medical/Dental Instruments
      Health Care

    $CTS
    $PRCT
    SEC Filings

    See more
    • CTS Corporation filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

      8-K - CTS CORP (0000026058) (Filer)

      7/2/25 11:33:56 AM ET
      $CTS
      Electrical Products
      Technology
    • SEC Form 144 filed by PROCEPT BioRobotics Corporation

      144 - PROCEPT BioRobotics Corp (0001588978) (Subject)

      6/6/25 4:22:07 PM ET
      $PRCT
      Medical/Dental Instruments
      Health Care
    • SEC Form SD filed by CTS Corporation

      SD - CTS CORP (0000026058) (Filer)

      5/30/25 12:19:08 PM ET
      $CTS
      Electrical Products
      Technology

    $CTS
    $PRCT
    Financials

    Live finance-specific insights

    See more
    • CTS Corporation Announces Date for Second Quarter 2025 Earnings Release and Conference Call

      LISLE, Ill., July 14, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS) will release its earnings for the second quarter 2025 at approximately 8:00 a.m. (ET) on Thursday, July 24, 2025. A conference call to discuss second quarter 2025 results with management is scheduled for Thursday, July 24, 2025 at 10:00 a.m. (ET). The dial-in numbers for access from the U.S. are: +1-833-470-1428 (Toll-Free) and +1-404-975-4839 (Local), if calling from outside the U.S., please refer to Global Dial In Numbers to identify the applicable dial-in number for your location. The passcode is 932754. A live audio webcast of the conference call will be available and can be accessed directly from the Investors

      7/14/25 6:01:07 PM ET
      $CTS
      Electrical Products
      Technology
    • CTS Corporation Declares a Dividend

      LISLE, Ill., May 12, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of CTS Corporation (NYSE:CTS) has declared a cash dividend of $0.04 per share on outstanding shares of common stock, without par value, to be paid on July 25, 2025, to shareholders of record at the close of business on June 27, 2025. About CTS CTS Corporation (NYSE:CTS) is a leading designer and manufacturer of products that Sense, Connect and Move. CTS manufactures sensors, actuators and electronic components in North America, Europe and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical and transportation markets. For more information, visit www.ctscorp.com. Contact Ash

      5/12/25 8:33:19 PM ET
      $CTS
      Electrical Products
      Technology
    • CTS Announces First Quarter 2025 Results

      LISLE, Ill., April 30, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS), a leading global designer and manufacturer of custom engineered solutions that "Sense, Connect and Move," today announced first quarter 2025 results. "Our global teams continued to execute well in a challenging operating environment. We delivered double digit sales growth in our diversified markets," said Kieran O'Sullivan, CEO of CTS Corporation. "Additionally, we had strong bookings in the quarter in the medical, aerospace and defense, and industrial markets. Diversification remains a strategic priority as we focus on growing our revenues and quality of earnings, both organically and through strategic acquisitio

      4/30/25 8:00:00 AM ET
      $CTS
      Electrical Products
      Technology

    $CTS
    $PRCT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by PROCEPT BioRobotics Corporation

      SC 13G/A - PROCEPT BioRobotics Corp (0001588978) (Subject)

      11/14/24 1:28:32 PM ET
      $PRCT
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by CTS Corporation

      SC 13G/A - CTS CORP (0000026058) (Subject)

      11/14/24 1:28:29 PM ET
      $CTS
      Electrical Products
      Technology
    • SEC Form SC 13G filed by CTS Corporation

      SC 13G - CTS CORP (0000026058) (Subject)

      11/14/24 12:28:26 PM ET
      $CTS
      Electrical Products
      Technology